Morquio Syndrome Treatment Market, Global Outlook and Forecast 2022-2028

July 2024 | 102 pages | ID: M6EFBA58E704EN
Market Monitor Global

Abstracts

Morquio syndrome is a type of mucopolysaccharide metabolic disorder, that is, type ? in mucopolysaccharide storage disease, also known as hereditary cartilage dystrophy syndrome

This report contains market size and forecasts of Morquio Syndrome Treatment in Global, including the following market information:

Global Morquio Syndrome Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Morquio Syndrome Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Morquio A Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Morquio Syndrome Treatment include BioMarin, Genzyme Corporation,, Shire, JCR Pharmaceuticals, Sanofi, Sangamo Therapeutics, Green Cross, Concert Pharmaceuticals and Alexion Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Morquio Syndrome Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Morquio Syndrome Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Morquio Syndrome Treatment Market Segment Percentages, by Type, 2021 (%)

• Morquio A
• Morquio B

Global Morquio Syndrome Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Morquio Syndrome Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Morquio Syndrome Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Morquio Syndrome Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Morquio Syndrome Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Morquio Syndrome Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• BioMarin
• Genzyme Corporation,
• Shire
• JCR Pharmaceuticals
• Sanofi
• Sangamo Therapeutics
• Green Cross
• Concert Pharmaceuticals
• Alexion Pharmaceuticals
• Roche
• Pfizer
• Lupin
• Cambrex Corporation
• Cipla
• Bayer
• Daiichi Sankyo

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Morquio Syndrome Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Morquio Syndrome Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MORQUIO SYNDROME TREATMENT OVERALL MARKET SIZE

2.1 Global Morquio Syndrome Treatment Market Size: 2021 VS 2028
2.2 Global Morquio Syndrome Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Morquio Syndrome Treatment Players in Global Market
3.2 Top Global Morquio Syndrome Treatment Companies Ranked by Revenue
3.3 Global Morquio Syndrome Treatment Revenue by Companies
3.4 Top 3 and Top 5 Morquio Syndrome Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Morquio Syndrome Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Morquio Syndrome Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Morquio Syndrome Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Morquio Syndrome Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Morquio Syndrome Treatment Market Size Markets, 2021 & 2028
  4.1.2 Morquio A
  4.1.3 Morquio B
4.2 By Type - Global Morquio Syndrome Treatment Revenue & Forecasts
  4.2.1 By Type - Global Morquio Syndrome Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Morquio Syndrome Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Morquio Syndrome Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Morquio Syndrome Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Morquio Syndrome Treatment Revenue & Forecasts
  5.2.1 By Application - Global Morquio Syndrome Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Morquio Syndrome Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Morquio Syndrome Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Morquio Syndrome Treatment Market Size, 2021 & 2028
6.2 By Region - Global Morquio Syndrome Treatment Revenue & Forecasts
  6.2.1 By Region - Global Morquio Syndrome Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Morquio Syndrome Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Morquio Syndrome Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Morquio Syndrome Treatment Revenue, 2017-2028
  6.3.2 US Morquio Syndrome Treatment Market Size, 2017-2028
  6.3.3 Canada Morquio Syndrome Treatment Market Size, 2017-2028
  6.3.4 Mexico Morquio Syndrome Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Morquio Syndrome Treatment Revenue, 2017-2028
  6.4.2 Germany Morquio Syndrome Treatment Market Size, 2017-2028
  6.4.3 France Morquio Syndrome Treatment Market Size, 2017-2028
  6.4.4 U.K. Morquio Syndrome Treatment Market Size, 2017-2028
  6.4.5 Italy Morquio Syndrome Treatment Market Size, 2017-2028
  6.4.6 Russia Morquio Syndrome Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Morquio Syndrome Treatment Market Size, 2017-2028
  6.4.8 Benelux Morquio Syndrome Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Morquio Syndrome Treatment Revenue, 2017-2028
  6.5.2 China Morquio Syndrome Treatment Market Size, 2017-2028
  6.5.3 Japan Morquio Syndrome Treatment Market Size, 2017-2028
  6.5.4 South Korea Morquio Syndrome Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Morquio Syndrome Treatment Market Size, 2017-2028
  6.5.6 India Morquio Syndrome Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Morquio Syndrome Treatment Revenue, 2017-2028
  6.6.2 Brazil Morquio Syndrome Treatment Market Size, 2017-2028
  6.6.3 Argentina Morquio Syndrome Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Morquio Syndrome Treatment Revenue, 2017-2028
  6.7.2 Turkey Morquio Syndrome Treatment Market Size, 2017-2028
  6.7.3 Israel Morquio Syndrome Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Morquio Syndrome Treatment Market Size, 2017-2028
  6.7.5 UAE Morquio Syndrome Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 BioMarin
  7.1.1 BioMarin Corporate Summary
  7.1.2 BioMarin Business Overview
  7.1.3 BioMarin Morquio Syndrome Treatment Major Product Offerings
  7.1.4 BioMarin Morquio Syndrome Treatment Revenue in Global Market (2017-2022)
  7.1.5 BioMarin Key News
7.2 Genzyme Corporation,
  7.2.1 Genzyme Corporation, Corporate Summary
  7.2.2 Genzyme Corporation, Business Overview
  7.2.3 Genzyme Corporation, Morquio Syndrome Treatment Major Product Offerings
  7.2.4 Genzyme Corporation, Morquio Syndrome Treatment Revenue in Global Market (2017-2022)
  7.2.5 Genzyme Corporation, Key News
7.3 Shire
  7.3.1 Shire Corporate Summary
  7.3.2 Shire Business Overview
  7.3.3 Shire Morquio Syndrome Treatment Major Product Offerings
  7.3.4 Shire Morquio Syndrome Treatment Revenue in Global Market (2017-2022)
  7.3.5 Shire Key News
7.4 JCR Pharmaceuticals
  7.4.1 JCR Pharmaceuticals Corporate Summary
  7.4.2 JCR Pharmaceuticals Business Overview
  7.4.3 JCR Pharmaceuticals Morquio Syndrome Treatment Major Product Offerings
  7.4.4 JCR Pharmaceuticals Morquio Syndrome Treatment Revenue in Global Market (2017-2022)
  7.4.5 JCR Pharmaceuticals Key News
7.5 Sanofi
  7.5.1 Sanofi Corporate Summary
  7.5.2 Sanofi Business Overview
  7.5.3 Sanofi Morquio Syndrome Treatment Major Product Offerings
  7.5.4 Sanofi Morquio Syndrome Treatment Revenue in Global Market (2017-2022)
  7.5.5 Sanofi Key News
7.6 Sangamo Therapeutics
  7.6.1 Sangamo Therapeutics Corporate Summary
  7.6.2 Sangamo Therapeutics Business Overview
  7.6.3 Sangamo Therapeutics Morquio Syndrome Treatment Major Product Offerings
  7.6.4 Sangamo Therapeutics Morquio Syndrome Treatment Revenue in Global Market (2017-2022)
  7.6.5 Sangamo Therapeutics Key News
7.7 Green Cross
  7.7.1 Green Cross Corporate Summary
  7.7.2 Green Cross Business Overview
  7.7.3 Green Cross Morquio Syndrome Treatment Major Product Offerings
  7.7.4 Green Cross Morquio Syndrome Treatment Revenue in Global Market (2017-2022)
  7.7.5 Green Cross Key News
7.8 Concert Pharmaceuticals
  7.8.1 Concert Pharmaceuticals Corporate Summary
  7.8.2 Concert Pharmaceuticals Business Overview
  7.8.3 Concert Pharmaceuticals Morquio Syndrome Treatment Major Product Offerings
  7.8.4 Concert Pharmaceuticals Morquio Syndrome Treatment Revenue in Global Market (2017-2022)
  7.8.5 Concert Pharmaceuticals Key News
7.9 Alexion Pharmaceuticals
  7.9.1 Alexion Pharmaceuticals Corporate Summary
  7.9.2 Alexion Pharmaceuticals Business Overview
  7.9.3 Alexion Pharmaceuticals Morquio Syndrome Treatment Major Product Offerings
  7.9.4 Alexion Pharmaceuticals Morquio Syndrome Treatment Revenue in Global Market (2017-2022)
  7.9.5 Alexion Pharmaceuticals Key News
7.10 Roche
  7.10.1 Roche Corporate Summary
  7.10.2 Roche Business Overview
  7.10.3 Roche Morquio Syndrome Treatment Major Product Offerings
  7.10.4 Roche Morquio Syndrome Treatment Revenue in Global Market (2017-2022)
  7.10.5 Roche Key News
7.11 Pfizer
  7.11.1 Pfizer Corporate Summary
  7.11.2 Pfizer Business Overview
  7.11.3 Pfizer Morquio Syndrome Treatment Major Product Offerings
  7.11.4 Pfizer Morquio Syndrome Treatment Revenue in Global Market (2017-2022)
  7.11.5 Pfizer Key News
7.12 Lupin
  7.12.1 Lupin Corporate Summary
  7.12.2 Lupin Business Overview
  7.12.3 Lupin Morquio Syndrome Treatment Major Product Offerings
  7.12.4 Lupin Morquio Syndrome Treatment Revenue in Global Market (2017-2022)
  7.12.5 Lupin Key News
7.13 Cambrex Corporation
  7.13.1 Cambrex Corporation Corporate Summary
  7.13.2 Cambrex Corporation Business Overview
  7.13.3 Cambrex Corporation Morquio Syndrome Treatment Major Product Offerings
  7.13.4 Cambrex Corporation Morquio Syndrome Treatment Revenue in Global Market (2017-2022)
  7.13.5 Cambrex Corporation Key News
7.14 Cipla
  7.14.1 Cipla Corporate Summary
  7.14.2 Cipla Business Overview
  7.14.3 Cipla Morquio Syndrome Treatment Major Product Offerings
  7.14.4 Cipla Morquio Syndrome Treatment Revenue in Global Market (2017-2022)
  7.14.5 Cipla Key News
7.15 Bayer
  7.15.1 Bayer Corporate Summary
  7.15.2 Bayer Business Overview
  7.15.3 Bayer Morquio Syndrome Treatment Major Product Offerings
  7.15.4 Bayer Morquio Syndrome Treatment Revenue in Global Market (2017-2022)
  7.15.5 Bayer Key News
7.16 Daiichi Sankyo
  7.16.1 Daiichi Sankyo Corporate Summary
  7.16.2 Daiichi Sankyo Business Overview
  7.16.3 Daiichi Sankyo Morquio Syndrome Treatment Major Product Offerings
  7.16.4 Daiichi Sankyo Morquio Syndrome Treatment Revenue in Global Market (2017-2022)
  7.16.5 Daiichi Sankyo Key News

8 CONCLUSION


9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Morquio Syndrome Treatment Market Opportunities & Trends in Global Market
Table 2. Morquio Syndrome Treatment Market Drivers in Global Market
Table 3. Morquio Syndrome Treatment Market Restraints in Global Market
Table 4. Key Players of Morquio Syndrome Treatment in Global Market
Table 5. Top Morquio Syndrome Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Morquio Syndrome Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Morquio Syndrome Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Morquio Syndrome Treatment Product Type
Table 9. List of Global Tier 1 Morquio Syndrome Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Morquio Syndrome Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Morquio Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Morquio Syndrome Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Morquio Syndrome Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Morquio Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Morquio Syndrome Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Morquio Syndrome Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Morquio Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Morquio Syndrome Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Morquio Syndrome Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Morquio Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Morquio Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Morquio Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Morquio Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Morquio Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 30. BioMarin Corporate Summary
Table 31. BioMarin Morquio Syndrome Treatment Product Offerings
Table 32. BioMarin Morquio Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Genzyme Corporation, Corporate Summary
Table 34. Genzyme Corporation, Morquio Syndrome Treatment Product Offerings
Table 35. Genzyme Corporation, Morquio Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Shire Corporate Summary
Table 37. Shire Morquio Syndrome Treatment Product Offerings
Table 38. Shire Morquio Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 39. JCR Pharmaceuticals Corporate Summary
Table 40. JCR Pharmaceuticals Morquio Syndrome Treatment Product Offerings
Table 41. JCR Pharmaceuticals Morquio Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Morquio Syndrome Treatment Product Offerings
Table 44. Sanofi Morquio Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Sangamo Therapeutics Corporate Summary
Table 46. Sangamo Therapeutics Morquio Syndrome Treatment Product Offerings
Table 47. Sangamo Therapeutics Morquio Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Green Cross Corporate Summary
Table 49. Green Cross Morquio Syndrome Treatment Product Offerings
Table 50. Green Cross Morquio Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Concert Pharmaceuticals Corporate Summary
Table 52. Concert Pharmaceuticals Morquio Syndrome Treatment Product Offerings
Table 53. Concert Pharmaceuticals Morquio Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Alexion Pharmaceuticals Corporate Summary
Table 55. Alexion Pharmaceuticals Morquio Syndrome Treatment Product Offerings
Table 56. Alexion Pharmaceuticals Morquio Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Roche Corporate Summary
Table 58. Roche Morquio Syndrome Treatment Product Offerings
Table 59. Roche Morquio Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Pfizer Corporate Summary
Table 61. Pfizer Morquio Syndrome Treatment Product Offerings
Table 62. Pfizer Morquio Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Lupin Corporate Summary
Table 64. Lupin Morquio Syndrome Treatment Product Offerings
Table 65. Lupin Morquio Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Cambrex Corporation Corporate Summary
Table 67. Cambrex Corporation Morquio Syndrome Treatment Product Offerings
Table 68. Cambrex Corporation Morquio Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Cipla Corporate Summary
Table 70. Cipla Morquio Syndrome Treatment Product Offerings
Table 71. Cipla Morquio Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Bayer Corporate Summary
Table 73. Bayer Morquio Syndrome Treatment Product Offerings
Table 74. Bayer Morquio Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 75. Daiichi Sankyo Corporate Summary
Table 76. Daiichi Sankyo Morquio Syndrome Treatment Product Offerings
Table 77. Daiichi Sankyo Morquio Syndrome Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Morquio Syndrome Treatment Segment by Type in 2021
Figure 2. Morquio Syndrome Treatment Segment by Application in 2021
Figure 3. Global Morquio Syndrome Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Morquio Syndrome Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Morquio Syndrome Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Morquio Syndrome Treatment Revenue in 2021
Figure 8. By Type - Global Morquio Syndrome Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Morquio Syndrome Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Morquio Syndrome Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Morquio Syndrome Treatment Revenue Market Share, 2017-2028
Figure 12. US Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Morquio Syndrome Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Morquio Syndrome Treatment Revenue Market Share, 2017-2028
Figure 24. China Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Morquio Syndrome Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Morquio Syndrome Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Morquio Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. BioMarin Morquio Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Genzyme Corporation, Morquio Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Shire Morquio Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. JCR Pharmaceuticals Morquio Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi Morquio Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sangamo Therapeutics Morquio Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Green Cross Morquio Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Concert Pharmaceuticals Morquio Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Alexion Pharmaceuticals Morquio Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Roche Morquio Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Pfizer Morquio Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Lupin Morquio Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Cambrex Corporation Morquio Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Cipla Morquio Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Bayer Morquio Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Daiichi Sankyo Morquio Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)